PMDA drug package insert
ポリドカスクレロール0.5%注2mL
PMDA Prescription drug · カイゲンファーマ株式会社 · package insert Mar 25, 2026
Key facts
| Brand names | ポリドカスクレロール0.5%注2mL, ポリドカスクレロール1%注2mL, ポリドカスクレロール3%注2mL |
|---|---|
| Nonproprietary names | ポリドカノール |
| Companies | 製造販売元／カイゲンファーマ株式会社, 製造元／クロイスラーCo.GmbH（ドイツ）, 発売元／株式会社インテグラル |
| Product type | Prescription drug |
| Therapeutic category | 下肢静脈瘤硬化剤 |
| Therapeutic category codes | 873329 |
| YJ codes | 3329405A2029, 3329405A3025, 3329405A4021 |
| Approval numbers | 21800AMY10110000, 21800AMY10111000, 21800AMY10112000 |
| Package insert edition | 第3版 |
| Package insert date | Mar 25, 2026 |
| PMDA document key | 200343_3329405A2029_2 |
| PMDA company code | 200343 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: